This trial tested mock consent forms of 2,000, 4,000, and 6,000 words. The first two comprised the two experimental arms and the third the control arm. Phase II was conducted to identify the promising ...
The ALSTARS Trial is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of COYA 302 in patients with amyotrophic lateral sclerosis (ALS) ...
A randomised, double-blind gene therapy trial for Parkinson's disease has shown that injection of the glutamic acid decarboxylase (GAD) gene directly into the brain is safe and can significantly ...
Clinical trials are designed not just to test whether a treatment works, but to do so in a way that eliminates bias. Two common trial designs—open-label and double-blind—differ sharply in this ...
In a multicenter, double-blind trial, we randomly assigned mechanically ventilated adults with sepsis to receive dexmedetomidine (0.2 to 1.5 μg per kilogram of body weight per hour) or propofol (5 to ...
Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell therapy in ...
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in the United Kingdom Trials sponsored by the ...
During his reign (605 BCE-562 BCE), Nebuchadnezzar II, King of Babylon, Sumer, Akkad and all of the universe, decided that a diet consisting entirely of meat and wine ensured good health, and so ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback